PATENT CLAIM ANALYSIS

Application Number: 16269529
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-08
Patent Classification: ["514", "657000"]

Abstract:
A composition for the treatment of emesis comprising 8-hydroxy-2-(dipropylamino)tetralin in which the ratio of the S enantiomer of the 8-hydroxy-2-(dipropylamino)tetralin to the R enantiomer of the 8-hydroxy-2-(dipropylamino)tetralin is between 2:1 and 10:1, and a method of treating or preventing emesis with such a composition.

Claim (Index 16):
The method of  claim 7 , wherein the amount of R(+)-8-Hydroxy-2-(dipropylamino)tetralin administered is between 0.02 mg/kg and 0.04 mg/kg.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 99.0
- Lexical Diversity: 1.70588
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15894724', '13274106', '14337037', '12692128', '09985679']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7640247348442166
- 35 USC 102 Novelty (BERT): 0.5550068625814105
- Combined Prediction Score: 0.7431229476179361
- Mean Citation Score: 249.811546
- Max Citation Score: 456.65173
- Similarity Product: 281.6113214190054

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test